StockData

BGM Group Ltd. (BGM) stock

BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026Score 9/30
$8.01+0.13 (+1.71%)

Close on Nov 16, 2026Market cap $3.21BP/E –Yield –

BGM ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$11.12M, down 1751.0% from the year before. The highest annual figure on record is $7.37M in fiscal 2019.

Annual ebitda

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$11.12M-1751.0%
FY2024Sep 30, 2024$673.46K–
FY2023Sep 30, 2023-$1.47M-144.1%
FY2022Sep 30, 2022$3.33M-7.3%
FY2021Sep 30, 2021$3.59M-39.3%
FY2020Sep 30, 2020$5.92M-19.7%
FY2019Sep 30, 2019$7.37M+2.0%
FY2018Sep 30, 2018$7.23M–

More BGM figures

See a number that looks wrong?